Human salivary α-amylase (HSAmy) has three distinct functions relevant to oral health: (i) hydrolysis of starch; (ii) binding to hydroxyapatite; and (iii) binding to bacteria (e.g. viridans streptococci). Oral bacteria utilize the starch hydrolyzing activity of HSAmy to derive their nutrients from dietary starch. Localized acid production by bacteria, through the metabolism of maltose generated by HSAmy, can lead to the dissolution of tooth enamel, a critical step in dental caries formation. HSAmy is a component of the acquired enamel pellicle and is used by Streptococcus gordonii to colonize the oral cavity. Although the active site of HSAmy for starch hydrolysis is well characterized, the regions responsible for the bacterial binding are yet to be defined. Since HSAmy possesses several secondary saccharide-binding sites in which aromatic residues are prominently located, we hypothesized that one of the secondary saccharide-binding sites harboring the aromatic residues W316 and W388, may play an important role in bacterial binding. To test this hypothesis, the aromatic residues W316 and W388 were mutated to alanine. The wild type and the mutant enzymes were characterized for their abilities to exhibit enzyme activity, starch binding and bacterial binding. Our results clearly showed that (i) the mutants W316A and W388A were not impaired in starch binding or bacterial binding; (ii) mutation of aromatic residues at theses sites does not alter the overall conformation of the molecule; and (iii) the hydrolytic activity of the enzyme is unaffected against starch as substrates but reduced significantly against oligosaccharides.
Introduction α-Amylases (α-1,4-glucan-4-glucanohydrolases, EC 3.2.1.1) are ubiquitous enzymes that catalyze the hydrolysis of starch and related polysaccharides containing α-1,4-glucosidic bonds. They belong to the glycoside hydrolase family 13 (MacGregor et al. 2001) and are widespread in all three domains of life. In humans, α-amylase is present in both salivary and pancreatic secretions and exhibits a high level of structural similarity (Brayer et al. 1995; Ramasubbu et al. 1996) . Human salivary α-amylase (HSAmy) is an important enzyme in the oral cavity carrying out several functions (Scannapieco et al. 1995) . HSAmy consists of a single polypeptide chain of 496 amino acids (Ramasubbu et al. 1996) and exists in several isoforms in the salivary secretions. Structurally, HSAmy consists of three domains: domain A (residues 1-99, 170-404), domain B (residues 100-169) and domain C (residues 405-496). The domain A adopts a (β/α) 8 -barrel structure bearing three catalytic residues Asp197, Glu233 and Asp300. The domain B occurs as an excursion from domain A. Domain C forms an all-β-structure and seems to be an independent do-main with as yet unknown function (Ramasubbu et al. 1996) . The molecular structure adapted by HSAmy is similar to the other mammalian amylases including the human pancreatic α-amylase with which it shares a very high degree of sequence identity (∼ 97%).
HSAmy binds to numerically prominent species of oral streptococci, such as Streptococcus gordonii, S. crista and S. mitis (Handley et al. 1991 ) but not to S. sanguis, S. oralis, S. mutans, or Actinomyces viscosus (Brown et al. 1999; Douglas 1983; Scannapieco et al. 1989 Scannapieco et al. , 1993 . The amylase-binding bacterial species constitute a substantial proportion of the total cultivable flora from the human teeth (Scannapieco et al. 1994; Tseng et al. 1992) . Interestingly, these bacteria appear to colonize the mouth of animals that possess amylase activity and may have an evolutionary advantage over bacteria that do not possess a salivary protein-binding property. The binding of S. gordonii G9B to HSAmy is calcium independent, saturable and leads to a functionally irreversible complex (Scannapieco et al. 1989 ). Two S. gordonii proteins, AbpA (20 kDa) and AbpB (80 kDa), mediate binding of HSAmy to the bacteria (Douglas et al. 1990; Gwynn & Douglas 1994 ; Rogers et al. 1998; Scannapieco et al. 1992) . The gene encoding the 20 kDa AbpA has been cloned and studied extensively (Rogers et al. 1998; Rogers et al. 2001 ) and its role in biofilm formation has been reported (Loo et al. 2000) .
A recent study provided further support for the role of AbpA in human saliva-supported biofilm formation by S. gordonii (Rogers et al. 2001) . While significant progress has been made in studies regarding bacterial proteins that bind to HSAmy, very little is known about the molecular determinants of HSAmy that are essential for the interaction. Interestingly, biochemical studies have shown the existence of a similarity between substrate and bacterial binding sites (Scannapieco et al. 1990 ). Earlier crystallographic studies have shown that HSAmy possesses four secondary saccharide-binding sites ( Fig. 1 ) in addition to the active site . We hypothesized that S. gordonii might utilize one of these four secondary saccharide-binding sites for binding to HSAmy. In HSAmy, two aromatic residues, W316 and W388, occur in one of the secondary sites at the interface between the A domain and the C domain. Since this site (site 3) is located away from the active site, binding of bacteria at this site may be relevant to bacte-rial colonization since such binding would not interfere with the active site of the enzyme. To test whether or not the interface between domains A and C plays a role in bacterial binding, we generated two mutants W316A and W388A and studied their bacterial binding ability, hydrolysis of starch and oligosaccharide and their roles of in acarbose-binding through crystallographic analysis.
Material and methods

Expression and purification of recombinant amylase proteins
The expression and purification of the recombinant proteins was carried out using a Bac-To-Bac Baculovirus Expression System as outlined previously (Mishra et al. 2002; Ragunath et al. 2002) . The mutants targeting the sites 316 and 388 were generated as described earlier (Mishra et al. 2002; Ramasubbu et al. 2004 ). The primers used in the study are provided in Table 1 . Approximately 5 mg of purified proteins were obtained per liter of the culture.
Enzyme activity assays
Dinitrosalicylic acid assay was used for measuring the starch-hydrolyzing activity of HSAmy and mutants at 25 • C for 3 min in 20 mM phosphate buffer (pH 6.9) containing 6 mM NaCl using 1% soluble starch as substrate (Bernfeld 1955) . Hydrolysis of maltoheptaose was carried out as previously described (Mishra et al. 2002; Kandra et al. 2003; Remenyik et al. 2003; Ramasubbu et al. 2004 ).
Preparation of 125 I-labeled α-amylase and mutant proteins
Purified recombinant α-amylase (25 µg) was iodinated by the chloramine-T method in 100 µL of PBS (Greenwood et al. 1963 ). lodinated and not iodinated materials were separated from free iodine and reagents by gel filtration on columns (10 mL disposable pipettes) of Bio-Gel P6DG (Bio-Rad) equilibrated in PBS. Fractions of 1 mL were monitored for radioactivity with a gamma counter (model 5500; Beckman). Void volume materials were used for the subsequent studies.
In vitro interaction of 125 I-labeled α-amylase with bacteria Streptococcus gordonii was cultured in TSB-Y and washed and resuspended in PBS 0.1% lipid-free BSA. Cell density was calculated at A600. Experiments were performed in polypropylene microcentrifuge tubes precoated with 1.0% BSA (Sigma-Aldrich) to reduce the nonspecific interaction of the ligand with the tube walls. Reaction mixtures contained 0.1 mL of the bacterial suspension (Approximately 1 × 10 7 ), various amounts of 125 I-labeled protein, and buffer added to a total volume of 200 µL. Triplicate samples were incubated at 27 • C for 30 min, after which the reaction was terminated by centrifugation followed by three 1-mL washes with PBS. Finally, the pellets were resuspended in 200 µL of PBS. The amount of radioactivity bound to the bacteria was measured with a gamma counter (model 5500; Beckman) using 10 µL of the sample. Negligible radioactivity (less than 0.01%) was recovered in the control microcentrifuge tubes from reaction mixtures, which did not contain bacteria.
Structure determination of mutant and acarbose complexes
Crystals of the mutants W316A and W388A were grown using conditions previously described (Ramasubbu et al. 1991 (Ramasubbu et al. , 1996 using a final protein concentration of 8 mg/mL. Diffraction quality crystals appeared over a period of one week. The protein complexes with acarbose, were obtained by soaking the enzyme crystals with acarbose (1 mM final concentration) in 45% (+/-)-2-Methyl-2,4-pentanediol for 24 h and the soaked crystals were used for data collection. The crystals were mounted on loops (Hampton Research) and flash frozen to −170 • C in liquid nitrogen. Diffraction data were collected using synchrotron radiation at the CHESS beam line A-1 at liquid nitrogen temperatures and a ADSC Quantum 4 CCD detector. A total of 360 frames were collected with an exposure time of 10-15 s and an oscillation interval of 0.5 • to give a 99% complete data set to 1.6Å. Intensity data were integrated, scaled and reduced to structure factor amplitudes using HKL2000 suite of programs (Otwinowski & Minor 1997) . The unit cell parameters were found to be isomorphous with those of the wild type HSAmy . Refinement of the mutant structures was carried out using Refmac5 in the CCP4 package (CCP4 1994) wherein cycles of rigid body refinement, positional and thermal B factor refinements were carried out using the phase information from the native enzyme (PDB code: 1SMD). A test set consisting of 5% of reflections was used to monitor the R free behavior. Manual model rebuilding was carried out using COOT (Emsley & Cowtan 2004) . The complete polypeptide chains of the mutants were examined with Fo-Fc and 2Fo-Fc maps. During this process, the mutant structure clearly showed absence of side chain density for W316 and W388 in the individual structures. The residue at position 316 and 388 was changed to Ala to reflect the mutation and for the remainder of the refinement these residues were treated as such. A similar procedure was used for the refinement of the complex structures as well.
At this stage, clear-cut continuous density corresponding to the oligosaccharide ligand was observed in the active site region at subsites −2, −1, +1 and +2. However, no oligosaccharide atoms were included in the refinement until the refinement of the protein reached convergence. The identity of the sugar moieties (either 5-hydroxymethylchonduritol or 4-amino-4,6-dideoxy-α-Dglucose or glucose) was deduced from the presence or absence of density for the hydroxyl group of the side chain at position C5 in the ring . The refinement was continued by the inclusion of the sugar atoms. Further examination of the density maps revealed no additional binding sites in the complex.
Solvent molecules were added using the arp/warp procedure (Lamzin & Wilson, 1993) in the CCP4 package. The validity of the water molecules were assessed based on the following criteria: (i) the presence of a peak at least 3σ in the difference map with at least one hydrogen bond to a protein atom (N or O) or (ii) if the located water molecule were part of a water chain connecting protein atoms; and (iii) the water refined with a thermal factor less than 50Å 2 . Manual fitting was interspaced between refinements as and when necessary. The programs PROCHECK (Laskowski et al. 1993 ), CCP4 and COOT were used for model analysis of the final refined structures ( Table 2 ). The coordinates of the mutant structures (W316A, W388A) and of the complex structures (W316/acarbose PDB code: 3BLK and W388/acarbose, PDB code: 3BLP) have been deposited in the Protein Data Bank (Berman et al. 2007 ). Other structures used for comparison have the following PDB codes: 1SMD (HSAmy), 1MFV (HSAmy/acarbose), and 1MFU (∆306-310HSAmy/acarbose).
Results and discussion
Enzyme hydrolytic activity of the mutants The two mutant proteins of HSAmy were expressed using the Bac-To-Bac Baculovirus Expression system described in Material and methods and purified to study the role of these aromatic residues in bacterial binding. The specific activities for the hydrolysis of starch are given in Table 3 . Mutation at W316 or W388 did not affect the enzyme activity in any significant way as evident from their comparable starch hydrolyzing activity with respect to the wild type enzyme. Figure 2 provides the HPLC profiles for the hydrolysis of maltoheptaose by wild type and mutant enzymes. As can be seen, both mutants hydrolyze maltoheptaose and produce an action pattern similar to that of the wild type. However, the hydrolytic ability of these two mutants is lower compared to the wild type enzyme. Of the two mutant enzymes, W388A appears to be less affected Fig. 2 . HPLC analyses of the products of the reactions of HSAmy, W316A and W388A enzymes with maltoheptaose. Enzymes were at a concentration of 60 nM while the substrate used was 0.5 mM. The products were identified using standards and amylose as described previously . by the mutation than the W316A enzyme. Also, the two mutants produce less maltose than the wild type enzyme. The differences observed in the hydrolysis of starch as well as maltoheptaose were significantly dif- ferent as calculated by statistical analysis (p = 0.05).
Binding of 125 I-labeled mutants to S. gordonii The bacterial binding ability of the two mutants was unaltered with respect to the wild type (Fig. 3) . This result clearly demonstrated that the interface between A/C domains is not involved in bacterial binding.
Overall structure of the mutants The structure of the two mutants, as with the wild type structure of HSAmy, retains the overall structure. An important feature of the mutant structures is that irrespective of the mutation at the A/C domain interface, both structures in general exhibit an overall fold very similar to the native molecule (r.m.s. deviation, 0.41Å for W316A/acarbose and 0.38Å for W388A/acarbose). Some of the salient features of the α-amylase structures such as the chloride-binding site, the calcium-binding site, the mobile loop containing the His305 residue are all well-defined in the mutant complex structures. The two tryptophan residues at positions 316 and 388 in the mutant structures clearly show the absence of density corresponding to the side chain (Figs 4 a,b) .
Structures of the acarbose complexes
Examination of the structures of the acarbose complexes show that the saccharide binding in W316/acarbose and W388/acarbose was restricted to the active site only. At the active site of both the mutants, clear density was observed for 5 saccharide units (Figs 4c,d) .
As with the wild type enzyme, the acarbose molecule is modified in both the mutants involving condensation reactions. The reactions that need to occur at the active site to generate the observed modified acarbose are shown in Figure 5 . This pathway, in essence, is the same as outlined for the wild type to generate a hexasaccharide at the active site. However, only a pentasaccharide was modeled due to the absence of well-defined electron density for the HMC monomer at the non-reducing end. Unlike the wild type/acarbose The density for the bound oligosaccharide, contoured at 1 σ, is shown. Note that there are only five carbohydrate moieties that could be fitted. The identity of the residues were determined using the method described earlier . The final refined coordinates of the corresponding protein or oligosaccharide residues are overlaid and are shown as thick black lines.
structure, wherein two other sites were populated by an acarbose molecule, in the mutant/acarbose complexes these secondary sites were not populated. Mutation of either W316 or W388, clearly results in the inability of this site to bind an acarbose molecule as observed in the wild type. Interestingly, the third site involv- Hmc-Agl is commonly known as the acarviosine moiety. The initial step is the hydrolysis of acarbose to generate a trisaccharide and glucose. The HSAmy enzymes generate a hexasaccharide by the condensation of two units of the trisaccharide. After condensation, the newly formed oligosaccharide must shift towards the non-reducing end to attain the final bound state.
ing residues Y276 and W284, were also devoid of any bound acarbose molecule in sharp contrast to the wild type/acarbose structure. No clear perturbation of the structure was observed around these secondary sites. It is unclear how the absence of saccharide-binding ability at these sites could affect the enzymatic activity as described above. One possibility could be that binding at these secondary sites, especially at Y276/W284 and/or W316/W388 could alter the water channel that has been suggested to be important for the enzyme activity.
Conclusions
We have generated two mutants of HSAmy targeting the aromatic residues at the interface between A and C domains, which act as binding platforms for saccharide binding. Our studies show the mutation did not affect the overall conformation of HSAmy. Interestingly, these residues only affect the oligosaccharide hydrolysis and not starch hydrolysis. The condensation activity as observed in the crystals of HSAmy appears to be intact in the mutant crystals as well. Finally, the inability of these two mutants to weaken the ability of bacterial binding suggests that these sites/residues are not involved in bacterial binding.
